Citigroup
TRIB

Citigroup’s Trinity Biotech TRIB Stock Holding History

Citigroup’s Portfolio TRIB Stock Details TRIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-1
Closed -$2 – 5857
2023
Q4 		$2 Hold
1
– – ﹤0.01% 5664
2023
Q3 		$3 Hold
1
– – ﹤0.01% 5637
2023
Q2 		$4 Hold
1
– – ﹤0.01% 5533
2023
Q1 		$4 Hold
1
– – ﹤0.01% 5430
2022
Q4 		$4 Hold
1
– – ﹤0.01% 5732
2022
Q3 		$0 Hold
1
– – ﹤0.01% 6324
2022
Q2 		$0 Hold
1
– – ﹤0.01% 6666
2022
Q1 		$0 Hold
1
– – ﹤0.01% 6602
2021
Q4 		$0 Hold
1
– – ﹤0.01% 6093
2021
Q3 		$0 Hold
1
– – ﹤0.01% 6302
2021
Q2 		$0 Hold
1
– – ﹤0.01% 6404
2021
Q1 		$0 Hold
1
– – ﹤0.01% 7368
2020
Q4 		$0 Hold
1
– – ﹤0.01% 7633
2020
Q3 		$0 Hold
1
– – ﹤0.01% 7604
2020
Q2 		$0 Hold
1
– – ﹤0.01% 7679
2020
Q1 		$0 Hold
1
– – ﹤0.01% 7779
2019
Q4 		$0 Hold
1
– – ﹤0.01% 7806
2019
Q3 		$0 Hold
1
– – ﹤0.01% 7824
2019
Q2 		$0 Hold
1
– – ﹤0.01% 7858
2019
Q1 		$0 Hold
1
– – ﹤0.01% 7812
2018
Q4 		$0 Hold
1
– – ﹤0.01% 7837
2018
Q3 		$0 Hold
1
– – ﹤0.01% 7869
2018
Q2 		$0 Hold
1
– – ﹤0.01% 7740
2018
Q1 		$0 Hold
1
– – ﹤0.01% 7676
2017
Q4 		$0 Sell
1
-100
-99% -$2.58K ﹤0.01% 7655
2017
Q3 		$3K Hold
101
– – ﹤0.01% 6969
2017
Q2 		$3K Hold
101
– – ﹤0.01% 6906
2017
Q1 		$3K Hold
101
– – ﹤0.01% 6943
2016
Q4 		$3K Sell
101
-160
-61% -$5.51K ﹤0.01% 7029
2016
Q3 		$17K Hold
261
– – ﹤0.01% 6294
2016
Q2 		$15K Sell
261
-44
-14% -$2.48K ﹤0.01% 6329
2016
Q1 		$18K Buy
305
+19
+7% +$1.01K ﹤0.01% 6598
2015
Q4 		$16K Buy
286
+25
+10% +$1.48K ﹤0.01% 6604
2015
Q3 		$15K Buy
261
+20
+8% +$1.61K ﹤0.01% 6219
2015
Q2 		$22K Buy
241
+100
+71% +$8.66K ﹤0.01% 6052
2015
Q1 		$14K Buy
141
+118
+513% +$10.9K ﹤0.01% 6293
2014
Q4 		$2K Buy
23
+13
+130% +$1.12K ﹤0.01% 6878
2014
Q3 		$1K Sell
10
-27
-73% -$2.92K ﹤0.01% 6934
2014
Q2 		$4K Buy
37
+36
+3,600% +$4.27K ﹤0.01% 6551
2014
Q1 		$0 Hold
1
– – ﹤0.01% 7208
2013
Q4 		$0 Hold
1
– – ﹤0.01% 7156
2013
Q3 		$0 Hold
1
– – ﹤0.01% 6982
2013
Q2 		$0 Buy
+1
New +$83 ﹤0.01% 6796

Other funds holding TRIB

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
HAIM
Hunter Associates Investment Management Pittsburgh, Pennsylvania $756M AUM 19.99% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
SCM
Stonehill Capital Management New York $197M AUM 96.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
WCM
Whitefort Capital Management New York $339M AUM 52.48% 1-Year Est. Return
MAWA
Moss Adams Wealth Advisors Seattle, Washington $1.37B AUM 19.97% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $38.8B AUM 21.88% 1-Year Est. Return
BCM
Becker Capital Management Portland, Oregon $3.4B AUM 24.68% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Citigroup's TRIB Position: Q1 2024 in Review

Citigroup sold out of Trinity Biotech (TRIB) in Q1 2024, closing a stake of 1 share — an estimated $2 sold.

Citigroup first reported a position in TRIB in Q2 2013 and held it in 43 quarters. The position peaked at $22K in Q2 2015. 19 funds tracked by Wall St. Rank hold TRIB as of Q1 2024.

  • Citigroup reported no remaining Trinity Biotech position as of Q1 2024 after selling out during the quarter.
  • Citigroup sold 1 Trinity Biotech share in Q1 2024, an estimated $2.
  • Citigroup first reported a position in Trinity Biotech in Q2 2013 and held it in 43 quarters.
  • Citigroup's Trinity Biotech position peaked at $22K in Q2 2015.
  • 19 funds tracked by Wall St. Rank held Trinity Biotech as of Q1 2024.

Based on Citigroup's 13F filing for Q1 2024, filed 10 May 2024.